PE20150713A1 - Derivados de acido hialuronico modificados y uso de los mismos - Google Patents

Derivados de acido hialuronico modificados y uso de los mismos

Info

Publication number
PE20150713A1
PE20150713A1 PE2015000465A PE2015000465A PE20150713A1 PE 20150713 A1 PE20150713 A1 PE 20150713A1 PE 2015000465 A PE2015000465 A PE 2015000465A PE 2015000465 A PE2015000465 A PE 2015000465A PE 20150713 A1 PE20150713 A1 PE 20150713A1
Authority
PE
Peru
Prior art keywords
hyaluronic acid
acid derivatives
modified hyaluronic
compounds
carbon atoms
Prior art date
Application number
PE2015000465A
Other languages
English (en)
Spanish (es)
Inventor
Pietro Antonino Di
Francesca Cavazza
Paolo Caliceti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PE20150713A1 publication Critical patent/PE20150713A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PE2015000465A 2012-10-09 2013-10-07 Derivados de acido hialuronico modificados y uso de los mismos PE20150713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187828 2012-10-09

Publications (1)

Publication Number Publication Date
PE20150713A1 true PE20150713A1 (es) 2015-05-16

Family

ID=47022522

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000465A PE20150713A1 (es) 2012-10-09 2013-10-07 Derivados de acido hialuronico modificados y uso de los mismos

Country Status (21)

Country Link
US (1) US20150252120A1 (enExample)
EP (1) EP2906193B1 (enExample)
JP (1) JP2015533190A (enExample)
KR (1) KR20150065861A (enExample)
CN (1) CN104703583A (enExample)
AR (1) AR092922A1 (enExample)
AU (1) AU2013328842A1 (enExample)
BR (1) BR112015007823A2 (enExample)
CA (1) CA2886144A1 (enExample)
CL (1) CL2015000803A1 (enExample)
EA (1) EA201590708A1 (enExample)
HK (1) HK1210941A1 (enExample)
IL (1) IL238103A0 (enExample)
IN (1) IN2015DN02358A (enExample)
MX (1) MX2015004386A (enExample)
PE (1) PE20150713A1 (enExample)
PH (1) PH12015500585A1 (enExample)
SG (1) SG11201501992XA (enExample)
TW (1) TW201414478A (enExample)
WO (1) WO2014056841A1 (enExample)
ZA (1) ZA201503171B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI614005B (zh) * 2014-05-26 2018-02-11 National Taipei University Of Technology 水膠組合物的用途
DE102014016158A1 (de) * 2014-07-11 2016-01-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Behandlung von Magenbeschwerden
WO2017116273A1 (en) * 2015-12-30 2017-07-06 Asafov Alexander Vilenovich Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses
RU2625766C1 (ru) * 2016-07-19 2017-07-18 Александр Ливиевич Ураков Средство для экстренного восстановления голоса при внезапной афонии
JP7404228B2 (ja) * 2018-03-22 2023-12-25 持田製薬株式会社 非ステロイド性抗炎症性化合物結合アルギン酸誘導体
EP3793525A4 (en) * 2018-05-16 2022-02-16 Emory University Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
GB8713662D0 (en) 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US4839159A (en) 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
IT1251151B (it) 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6585987B1 (en) 1998-11-13 2003-07-01 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
EP1401875A4 (en) 2001-05-04 2005-01-26 Univ Utah Res Found HYALURONIC ACID-CONTAINING BIOKON JUGATES: TARGETED DELIVERY OF ANTIBODIES TO CANCER CELLS
ITMI20021666A1 (it) 2002-07-26 2004-01-26 Jasper Ltd Liability Co Derivati dell'acido ialuronico
US20110027357A1 (en) * 2004-02-18 2011-02-03 Isaac Gilinski Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en) 2004-12-21 2006-06-22 Avon Products, Inc. Cosmetic compositions having carnitine creatinate and methods for using
EP1833882A1 (en) 2004-12-30 2007-09-19 Novozymes Biopolymer A/S Hyaluronic acid linked with a polymer of an alpha hydroxy acid
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (en) 2006-08-01 2008-02-06 Auriga International S.A. Cosmetic or pharmaceutical composition containing hyaluronic acid
US20090312421A1 (en) 2007-05-11 2009-12-17 Sigma-Tau Industrie Farmaceutiche Riunite Spa Gel useful for the delivery of cosmetic active ingredients
BRPI0811777A2 (pt) 2007-05-23 2019-09-24 Allergan Inc partículas de ácido hialurõnico revestidas
WO2010003797A1 (en) 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing

Also Published As

Publication number Publication date
BR112015007823A2 (pt) 2017-07-04
AR092922A1 (es) 2015-05-06
US20150252120A1 (en) 2015-09-10
EP2906193A1 (en) 2015-08-19
JP2015533190A (ja) 2015-11-19
PH12015500585A1 (en) 2015-05-04
KR20150065861A (ko) 2015-06-15
CL2015000803A1 (es) 2015-08-07
IN2015DN02358A (enExample) 2015-09-04
HK1210941A1 (en) 2016-05-13
EP2906193B1 (en) 2016-09-28
EA201590708A1 (ru) 2015-07-30
AU2013328842A1 (en) 2015-04-09
TW201414478A (zh) 2014-04-16
CN104703583A (zh) 2015-06-10
SG11201501992XA (en) 2015-04-29
WO2014056841A1 (en) 2014-04-17
CA2886144A1 (en) 2014-04-17
MX2015004386A (es) 2015-06-10
ZA201503171B (en) 2016-11-30
IL238103A0 (en) 2015-05-31

Similar Documents

Publication Publication Date Title
PE20150713A1 (es) Derivados de acido hialuronico modificados y uso de los mismos
MX2015001751A (es) Composicion topica comprendiendo bacterias transformadas que expresan un compuesto de interes.
CR20160272A (es) REGULADORES DE Nrf2
UY35700A (es) Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística
BR112016007572A8 (pt) composição, composição de fixador para os cabelos e método para a produção uma poligalactomanana dihidroxipropil-substituída
CR20150117A (es) Derivados c17-alcandilo y alquendilo del ácido oleanólico y sus métodos de uso
UY33526A (es) Nuevas aminopirazoloquinazolinas
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
BR112013031463A2 (pt) piridina-2-amidas úteis como agonistas de cb2
ECSP13012482A (es) Derivados de 5-yodo-triazol
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
CR20140195A (es) Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas
BR112013008667A2 (pt) compostos substituídos de benzamida
BR112015008954A2 (pt) composições de ciclodextrina alquilatada e processos para preparação e uso das mesmas
ECSP15013883A (es) Benzamidas
CR20150583A (es) Instalación para la preparación de una solución de carbonato ácido de calcio adecuada para la remineralización del agua
GT201500247A (es) Imidazopiridazinas sustituidas
BR112015007422A2 (pt) novos compostos farmacêuticos
UY32404A (es) 4-aril-butan-1,3-diamidas
MX2013002948A (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
NI201600006A (es) Pirazolo-piridinaminas sustituidas
FR3006178B1 (fr) Utilisation cosmetique comme actif deodorant d'un materiau silicie obtenu par hydrolyse et condensation d'un tetraalcoxysilane et d'un c7-c20-alkyl trialcoxysilane
ECSP14026432A (es) (r)-nifuratel y síntesis de (r) y (s)-nifuratel
MX2014003840A (es) Metodo para reducir la transpiracion y composiciones antitranspirantes.
MX343517B (es) 2,4 pirimidinadiaminas sustituidas para su uso en lupus discoide.

Legal Events

Date Code Title Description
FD Application declared void or lapsed